Screeners
Heatmaps
Trends
News

You're viewing limited data.

Sign up

1 asset

Market news

TypeAll

SortNewest

Assets

TBPH

Type

TypeAll

All

Sort

SortNewest

Newest

Filter by asset

Zymeworks Updates Annual Financial Targets After Finalizing Theravance Biopharma Deal - Zymeworks (NASDAQ

Zymeworks completes its Theravance Biopharma acquisition, boosts 2026 revenue guidance, and gains recurring revenue from YUPELRI sales.

Sep 28Benzinga

Zymeworks Inc. (ZYME) Theravance Biopharma, Inc. - M&A Call - Slideshow (NASDAQ:ZYME) 2026-09-28

Sep 28Seeking Alpha

Zymeworks completes acquisition of Theravance Biopharma

Sep 23Investing.com

Theravance Biopharma shareholders approve merger with Zymeworks

Sep 18Investing.com

Zymeworks' Theravance Deal Is A Breath Of Fresh Cash Flow (NASDAQ:ZYME)

Sep 18Seeking Alpha

Theravance Biopharma (TBPH) Presents At Cantor Fitzgerald Global Healthcare Conference - Slideshow (NASDAQ:TBPH-DEFUNCT-155603) 2017-09-27

Sep 18Seeking Alpha

Theravance Biopharma SVP Rhonda Farnum sells $226k in stock

Sep 17Investing.com

Theravance Bio (TBPH) Up 0.8% Since Last Earnings Report: Can It Continue?

Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sep 9Yahoo Finance

Theravance Biopharma earnings missed by $0.17, revenue fell short of estimates

Aug 10Investing.com

Theravance Bio: Q2 Earnings Snapshot

Theravance Bio: Q2 Earnings Snapshot

Aug 10Barchart.com

This is the newest page. Registered accounts read further back.